American Research & Management Company’s Amplify Alternative Harvest ETF MJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$13K Hold
229
﹤0.01% 280
2022
Q2
$16K Hold
229
﹤0.01% 275
2022
Q1
$29K Hold
229
0.01% 235
2021
Q4
$30K Hold
229
0.01% 233
2021
Q3
$40K Buy
229
+169
+282% +$34.5K 0.01% 218
2021
Q2
$15K Hold
60
﹤0.01% 289
2021
Q1
$16K Hold
60
﹤0.01% 269
2020
Q4
$10K Hold
60
﹤0.01% 292
2020
Q3
$7K Hold
60
﹤0.01% 278
2020
Q2
$9K Hold
60
﹤0.01% 271
2020
Q1
$8K Hold
60
﹤0.01% 269
2019
Q4
$12K Hold
60
﹤0.01% 266
2019
Q3
$15K Buy
60
+11
+22% +$3.55K ﹤0.01% 262
2019
Q2
$19K Buy
49
+12
+32% +$4.84K 0.01% 262
2019
Q1
$16K Buy
+37
New +$15.3K ﹤0.01% 298

Other funds holding MJ

American Research & Management Company's MJ Position: Q3 2022 in Review

American Research & Management Company held its Amplify Alternative Harvest ETF (MJ) position steady in Q3 2022 at 229 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #280.

American Research & Management Company first reported a position in MJ in Q1 2019 and has held it in 15 quarters since. The position peaked at $40K in Q3 2021. 249 funds tracked by Wall St. Rank hold MJ as of Q3 2022.

  • American Research & Management Company held 229 shares of Amplify Alternative Harvest ETF worth $13K as of Q3 2022.
  • American Research & Management Company left its Amplify Alternative Harvest ETF share count unchanged in Q3 2022.
  • Amplify Alternative Harvest ETF made up ﹤0.01% of American Research & Management Company's portfolio in Q3 2022, its #280 holding.
  • American Research & Management Company first reported a position in Amplify Alternative Harvest ETF in Q1 2019 and has held it in 15 quarters since.
  • American Research & Management Company's Amplify Alternative Harvest ETF position peaked at $40K in Q3 2021.
  • 249 funds tracked by Wall St. Rank held Amplify Alternative Harvest ETF as of Q3 2022.

Based on American Research & Management Company's 13F filing for Q3 2022, filed 7 Oct 2022.